Description
Retatrutide (LY-3437943) is a triple receptor agonist acting on the GLP-1, GIP and glucagon pathways — one of the most closely watched next-generation compounds in metabolic and body-composition research. Supplied as 5 vials × 24 mg lyophilized peptide with bacteriostatic water. For laboratory and research use only — not for human consumption.


Reviews
There are no reviews yet.